GENE ONLINE|News &
Opinion
Blog

2026-02-11|

Sands China Partners with Alipay and Macau Pass to Expand Cashless Payment Systems in Macau

by GOAI
Share To

Sands China Ltd., Alipay, and Macau Pass have announced an expanded partnership aimed at advancing digital transformation efforts in Macau. The collaboration focuses on enhancing digital payment systems and streamlining services for residents and tourists in the region. The initiative seeks to integrate advanced technologies to improve user experiences across Sands China’s properties while supporting Macau’s broader push toward a more digitally connected economy.

The partnership will leverage Alipay’s expertise in mobile payment solutions and Macau Pass’s local network to introduce upgraded digital payment options. This includes seamless integration of cashless transactions at Sands China’s resorts, retail outlets, and entertainment venues. The companies also plan to explore innovative features such as loyalty programs, personalized promotions, and other digital tools designed to enhance customer engagement. This joint effort aligns with ongoing efforts by businesses in Macau to modernize infrastructure and cater to the growing demand for convenient, technology-driven services.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 12, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Oragenics Submits Annual Report Highlighting Fiscal Year 2025 Financials and Research Updates
2026-03-17
SurgePays Launches Nationwide Campaign to Promote LinkUp Mobile Service
2026-03-17
Tempus and Blood Cancer United Collaborate to Build Extensive Pediatric AML Data Registry
2026-03-17
John Choe Appointed Western Sales Director at Buzz Bomb Caffeine Company
2026-03-17
Two RXO Leaders Earn Fourth Consecutive Recognition in Supply Chain Pros to Know Awards
2026-03-17
Pfizer Reports Phase 2 Trial Success for Atirmociclib in Second-Line Metastatic Breast Cancer Treatment
2026-03-17
Merck to Present Long-Term Efficacy Data on GARDASIL9 and GARDASIL at EUROGIN 2026
2026-03-17
Scroll to Top